Home >> Industry News >> Guardant360 CDx OK’d as companion diagnostic for Enhertu

Guardant360 CDx OK’d as companion diagnostic for Enhertu

image_pdfCreate PDF

Guardant360 CDx provides comprehensive genomic results from a blood draw in seven days and covers all genes recommended by the National Comprehensive Cancer Network.

CAP TODAY
X